Research – Pyxis Tankers (PXS) – 2018 financial update

Posted on March 29, 2019 by Admin

Friday, March 29, 2019

Pyxis Tankers (PXS)

When Will The Refined Product Tanker Market Recover?

Pyxis Tankers Inc is a US-based international maritime transportation company which focuses on the product tanker sector. It owns a fleet which comprises of six double hull product tankers, which are employed under a mix of short- and medium-term time charters and spot charters.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

Another tough
quarter due to rate weakness. Adjusted 4Q2018 EBITDA of $0.2 million was below $1.0 million
in 4Q2017 due to weaker MR tanker rates. Record low MR rates early in 4Q2018
caused a shortfall in TCE revenue (-$0.94 million) and more than offset positive
variances in opex ($0.15 million) and G&A expenses ($0.30 million).
Adjusting 2019
Estimate to reflect new contracts and 2H2019 recovery. Our 2019 EBITDA estimate moves to $6.9 million (from
$7.9 mill…

Get full report on Channelchek desktop.

*Analyst
certification and important disclosures included in full report.
NOTE: investment decisions should not be based upon the content of
this research summary. Proper due diligence is required before
making any investment decision.

Podcast Launch: The Science of Investing in Biotechs

Posted on March 28, 2019 by Admin

First Episode: The science of investing in biotechs

In the inaugural episode, Brant Pinvidic (host of the iTunes top-trending Hollywood podcast “Why I’m Not…”) tries to navigate the minefield of challenges that biotech investors face. In his engaging everyman approach, Brant looks at the importance of getting a third-party, independent opinion, how to determine what’s real and unreal about patent protection and intellectual property, and probes into where you might find the next breakthrough in medicine. He’s not alone on this challenge. Joined by four of the members of the Noble Scientific Advisory Board – the who’s who of life sciences – together they show you how a detailed and disciplined approach, in this risk-reward-rich field, is the true science behind investing in biotechs.

Who should listen? Anyone who wants to invest in life science companies but may be afraid; EVERY CEO and CFO of a biotech company, as this elite group will be sure to provide some eye-openers; investment professionals who can help advise their clients in what to look for… and what to avoid when trying to sift through the hundreds and hundreds of life sciences companies, and find that gem to invest in, and; anyone interested in a lively debate among some of the world’s greatest minds in medicine…

The most innovative Ideas, the inspirational People behind them, and the wealth of Opportunities they create… that’s IPO from Channelchek.

watch the IPO series trailer

A Video Introduction to Enochian Biosciences

Posted on March 28, 2019 by Admin

Enochian Biosciences Inc. is a biopharmaceutical levering its gene therapy platform to treat patients with HIV/AIDS. The company has a diverse pipeline at the preclinical and discovery stage to treat and prevent infectious disease and cancer. In the infectious disease front, there are two key products i) the lead candidate, genetically modified cell therapy ENO-1001, that is currently at preclinical stage for treatment of patients with HIV/AIDS and ii) ENO-2001, a vaccine, to prevent HIV infection. In the oncology front, Enochian is developing agents ENO-1002, ENO-3001, and ENO-5001 to treat patients with relapse metastatic colon cancer. The company has established research and development agreements with Scripps Research Institute to conduct pre-new drug application (pre-IND) work to advance ENO-1001 in the clinic, and with University of California Los Angles (UCLA) to advance HIV program. Enochian BioSciences is headquartered in Los Angeles, California.

Link to Enochian page on Channelchek

Research – Dyadic (DYAI) – 2018 full year update

Posted on March 28, 2019 by Admin

Thursday, March 28, 2019

Dyadic International (DYAI)

Could 2019 be transformational?

Dyadic International Inc. is a biotechnology company developing a proprietary expression platform to manufacture of biologic products. The company is employing C1 technology, part of a fungi expression system, to produce variety of modalities of biologic products, including vaccines, oncolytic viruses, monoclonal and bispecific antibodies, as well as biosimilars.

Ahu Demir, Ph.D., Biotechnology Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

R&D
Advancement. The company continues to make progression in
establishing C1 expression production and the purification process in multiple
projects. The Schmallenberg virus (SBV) as part of the ZAPI project exceeded
the intended expression levels (17x), and is potentially the first to enter in
human trials. We believe glycan engineering intended in 2019 could be
transformational for the company.
Corporate
Updates. The proof of concept collaborations totaled nine projects,
including two newly added agreements with large pharmaceuticals in Q1 2019.
Dyadic continues to validate C1’s potential in biologic manufacturing, guiding
an $8-$10 million burn rate this year. However, business development efforts
are ongo…

Get full report on Channelchek desktop.

Official Trailer: NEW Podcast Series- Icons of Business, Leaders of Emerging Companies

Posted on March 26, 2019 by Admin

The NEW podcast series, from top-trending iTunes host, Brant Pinvidic, features celebrity CEOs of iconic brands you know and love, to the emerging growth companies and entrepreneurs you should be talking about. The most innovative Ideas, the inspirational People behind them, and the wealth of Opportunities they create… that’s IPO from Channelchek.

CLICK HERE TO WATCH THE TRAILER

Upcoming episodes – first episode this Thursday

Kathy Ireland: From Supermodel, to socks, to mega-success (and a few failures along the way).

Christie Hefner: The best person for the job… running Playboy Enterprises for almost as long as Hef himself!

Artificial Intelligence: Could a person who is born 10 years from now, live to 120? Billionaires are banking on it.

The science of Investing in Biotechs: A world-class scientific advisory board (SAB) helps you steer through this formidable minefield.

David Weild IV: How the father of the JOBS ACT sees the future for emerging growth companies.

News – The Case for Dr. Copper: New Sources of Demand are Positive for Copper

Posted on March 25, 2019 by Admin

Betting on The Future of Copper.

(Note: companies that could be impacted by the content of this article are listed at the base of the story (desktop version). This article uses third-party references to provide a bullish, bearish and balanced point of view; sources listed in the “Balanced” section)

Copper is prized for its extensive applications, including
as a component in electronics and motor vehicles. It is called Dr. Copper because it is often
viewed as a leading indicator of changes in the business cycle given its use in
many sectors of the economy. Demand for
copper is poised to benefit from greater usage for electric vehicles,
communications and clean energy systems, such as solar thermal plants. Bloomberg recently published an article
highlighting that more than a third of capital spending by a group of large
diversified miners is being dedicated to copper, up from 20% or less earlier in
the decade, to prepare for demand growth.

Research – 1-800-Flowers.com (FLWS) – Investor Day Highlights

Posted on March 25, 2019 by Admin

Monday, March 25, 2019

1-800-Flowers.com, Inc (FLWS)

Not resting on its florals.

1-800 Flowers.com Inc
is a United-States-based provider of gourmet food & gift baskets, consumer
floral, and BloomNet wire service. Gourmet food & gift baskets and consumer
floral jointly account for the majority of the company’s total revenue. The
company provides a broad range of merchandise, including fresh flowers,
premium, fruits, popcorn, specialty treats, cookies and baked gifts, premium
chocolates, confectionery, gift baskets, premium English muffins, steaks and
chops, and others.

Michael Kupinski, DOR, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

Investor day reinforces strategy. The company held an Investor Day on March 22nd with detailed
presentations from key management personnel from consumer floral and the
gourmet food brands. The overall theme, highlighted across each of the business
segments, were centered around investments in new customer acquisition,
technological innovations, and increase cross-brand marketing efforts.
Holiday revenues strong. The Company provided color on the recent February 2019
Valentine’s Day holiday period, which displayed continued efforts to gain
market share. As this holiday time period is primarily heavy in floral
revenues, bot…

Get full report on Channelchek desktop.

Research – Torchlight Energy – Strong updates on project estimates

Posted on March 25, 2019 by Admin

Monday, March 25, 2019

Torchlight Energy Resources (TRCH)

Surprising reserve data.

Torchlight Energy Resources Inc acquires, explores, exploits, and/or develops oil and natural gas properties in the United States. The company has an interest in four oil and gas projects namely the Orogrande Project in Hudspeth County, Texas, and the Hazel Project in Sterling, Tom Green, and Irion Counties, Texas, the Winkler Project in Winkler County, Texas, and the Hunton wells in partnership with Husky Ventures in Central Oklahoma.

Mike Heim, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

Torchlight Energy presented updated
information on its Orogrande project, significantly increasing its estimated
potential recoverable reserves. Just one week earlier, the company estimated that its
acreage could have 1.0 billion barrels of reserves. Today, in a
presentation to the investment community, it indicated it could have as much as
3.7 billion barrels.
Management believes the time to
sell the assets or the company is now! The company plans to make presentations to investors
beginning in April. Management said in a call with analysts that its
number one goal is to sell the company, but that other opti…

Get full report on Channelchek desktop.

Research – Information Services (III) – Favorable risk/reward moving forward

Posted on March 25, 2019 by Admin

Monday, March 25, 2019

Information Services Group (III)

What Are Recent Management Actions Indicating?

Information Services Group (ISG) (III) is a leading technology insights, market intelligence and advisory services company, serving more than 500 clients around the world to help them achieve operational excellence. ISG supports private and public sector organizations to transform and optimize their operational environments through research, benchmarking, consulting and managed services, with a focus on information technology, business process transformation, program management services and enterprise resource planning.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

Stepping into the market. In
a flurry of Form 4 filings, the top 3 III executives added to their already
substantial stock holdings through the purchase of III shares on the open
market. In total, CEO Michael Connors added 40,000 shares at prices in the
$3.70-$3.73 range, CFO David Berger added 2,050 in the $3.67-$3.79 range, and
Vice Chairman Todd Lavieri added 13,500 in the $3.69-$3.79 range.
It’s been awhile. Friday’s
Form 4 filings were the first open market purchases by CEO Connors since August
2017, when Mr. Connors added 13,514 shares over a series of purchases in the
$3.60-$3.70 range. Mr. Lavieri has a very limited Form 4 filing history, while
it would appear this is the first open mar…

Get full report on Channelchek desktop.

Research – Prize Mining (PRZ:CA) – Initiation of Research Coverage

Posted on March 25, 2019 by Admin

Monday, March 25, 2019

Prize Mining (PRZ:CA)

Building a Future on Copper.

Prize Mining Corp is a Canada based resource exploration company. It is primarily engaged in the business activity of acquiring and exploring resource properties in Canada. All the operations of the company are carried out in Canada. The organization is focused on Kena and Daylight Gold project which is located in the Nelson area of British Columbia, Canada.

Mark Reichman, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

Prize is largely a play
on expanding global demand for copper. While the Kena gold project is under strategic review,
the Manto Negro project is where management is positioning itself to focus the
greatest resources going forward in order to capitalize on expected growth in
copper demand.
Phase II drilling program
at Manto Negro. Management’s key objective at both projects has been
to consolidate contiguous land packages to form district-scale projects and to
build resources and reserves. Phase I and II drilling programs have been
completed at the Kena project and a Phase I drilling program has been completed
at Manto Negro. A Phase II program will entail drilling another 3,000 to
5,000 meters in 2019 follow…

Get full report on Channelchek desktop.

Research – Cumulus Media (CMLS) — Raising Price Target

Posted on March 22, 2019May 4, 2022 by Admin

Friday, March 22, 2019

Cumulus Media (CMLS)

Raising our price target on a simple premise.

Cumulus Media, Inc., a radio broadcasting company, engages in the acquisition, operation, and development of commercial radio stations in mid-size radio markets in the United States. It owns and operates FM and AM radio station clusters that serve mid-sized markets. The company, through its investment in Cumulus Media Partners, LLC, also operates radio station clusters serving large-sized markets.

Michael Kupinski, DOR, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

Q4 over delivers. The company over delivered on its Q4 despite the
preannouncement for the quarter. Revenues and adjusted EBITDA were better than
expected, at $309.2 million and $66.6 million, respectively, compared to our
revenue and adjusted EBITDA estimates of $303.7 million and $57.4 million,
respectively. The better than expected revenue grow was driven primarily on the
strength of its digital business and a lift from political advertising.
Q1 shows improvement. Management indicated that advertising pacings in Q1
2019 is improving, better than its preliminary guidance in its preannounced
fourth quarter. Rev…

Get full report on Channelchek desktop.

Research – Pangaea Logistics (PANL) – Business Model/Strategy Shine

Posted on March 22, 2019 by Admin

Friday, March 22, 2019

Pangaea Logistics (PANL)

Amidst an uncertain industry, Pangaea stands out as unique and different.

Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk transportation services. It transports drybulk cargos including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite and limestone. The firm’s services include cargo loading, cargo discharge, vessel chartering, voyage planning and technical vessel management.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

Model of consistency.
Another solid quarter. The unique business model continues to deliver strong
results. 4Q2018 EBITDA of $12.2 million was ahead of expectations of $10.2
million due to wider than expected outperformance and higher charter in days.
While down sequentially from $16.6 million in 3Q2018, 4Q2018 EBITDA was almost
20% above 4Q2017 EBITDA of $10.7 million. TCE rates of $14,360/day improved
from $13,835/day in 3Q2018 and were ~15% above $12,505/day in 4Q2017.
Adjusting 2019
EBITDA estimate. Our EBITDA estimate moves to $62.7 million in 2019
(from $63.1 million). Our estimates are based on shipping days of 18,083 in
2019 (down from 18,803), up from 16,316 in 2018, and EBITDA per shipping day of
$3,349 in 2019 (down from $3,356), up from $3,343 in 2018. The recently
ac…

Get full report on Channelchek desktop.

Research – Seanergy (SHIP) – What do the results show?

Posted on March 21, 2019 by Admin

Thursday, March 21, 2019

Seanergy Maritime Holding Corp. (SHIP)

Weak operating results create good opportunity on pure cape market player.

Seanergy Maritime Holdings Corp., an international shipping
company, provides marine dry bulk transportation services through the ownership
and operation of dry bulk vessels. The company owns a modern fleet of 10
Capesize dry bulk vessels with a combined cargo-carrying capacity of
approximately 1,748,581 dwt and an average fleet age of 9.8 years. The company
was formerly known as Seanergy Maritime Corp. and changed its name to Seanergy
Maritime Holdings Corp. in January 2009.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to full report for price target, fundamental analysis and rating.

Weaker than expected 4Q2018 Due to
Cape Market Weakness. Reported adjusted 4Q2018 EBITDA of $6.3 million was well
below our estimate mainly due to lower time equivalent (TCE) rates and higher
than expected opex.
Adjusting 2019 EBITDA estimate to
reflect lower TCE rates. Cape market improvement expected later this year. To incorporate the current malaise in the cape market, our
2019 EBITDA estimate moves down sha…

Get full report on Channelchek desktop.